IBDEI1WB ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31746,1,3,0)
 ;;=3^Cannabis-Induced Anxiety Disorder w/ Mild Use Disorders
 ;;^UTILITY(U,$J,358.3,31746,1,4,0)
 ;;=4^F12.180
 ;;^UTILITY(U,$J,358.3,31746,2)
 ;;=^5003163
 ;;^UTILITY(U,$J,358.3,31747,0)
 ;;=F12.188^^138^1453^3
 ;;^UTILITY(U,$J,358.3,31747,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31747,1,3,0)
 ;;=3^Cannabis-Induced Sleep Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,31747,1,4,0)
 ;;=4^F12.188
 ;;^UTILITY(U,$J,358.3,31747,2)
 ;;=^5003164
 ;;^UTILITY(U,$J,358.3,31748,0)
 ;;=F12.20^^138^1453^4
 ;;^UTILITY(U,$J,358.3,31748,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31748,1,3,0)
 ;;=3^Cannabis Use Disorder,Moderate-Severe
 ;;^UTILITY(U,$J,358.3,31748,1,4,0)
 ;;=4^F12.20
 ;;^UTILITY(U,$J,358.3,31748,2)
 ;;=^5003166
 ;;^UTILITY(U,$J,358.3,31749,0)
 ;;=F12.21^^138^1453^5
 ;;^UTILITY(U,$J,358.3,31749,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31749,1,3,0)
 ;;=3^Cannabis Use Disorder,Moderate-Severe,In Remission
 ;;^UTILITY(U,$J,358.3,31749,1,4,0)
 ;;=4^F12.21
 ;;^UTILITY(U,$J,358.3,31749,2)
 ;;=^5003167
 ;;^UTILITY(U,$J,358.3,31750,0)
 ;;=F12.288^^138^1453^6
 ;;^UTILITY(U,$J,358.3,31750,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31750,1,3,0)
 ;;=3^Cannabis Withdrawal
 ;;^UTILITY(U,$J,358.3,31750,1,4,0)
 ;;=4^F12.288
 ;;^UTILITY(U,$J,358.3,31750,2)
 ;;=^5003176
 ;;^UTILITY(U,$J,358.3,31751,0)
 ;;=F12.280^^138^1453^7
 ;;^UTILITY(U,$J,358.3,31751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31751,1,3,0)
 ;;=3^Cannabis-Induced Anxiety Disorder w/ Moderate-Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,31751,1,4,0)
 ;;=4^F12.280
 ;;^UTILITY(U,$J,358.3,31751,2)
 ;;=^5003175
 ;;^UTILITY(U,$J,358.3,31752,0)
 ;;=F16.10^^138^1454^1
 ;;^UTILITY(U,$J,358.3,31752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31752,1,3,0)
 ;;=3^Phencyclidine Use Disorder,Mild
 ;;^UTILITY(U,$J,358.3,31752,1,4,0)
 ;;=4^F16.10
 ;;^UTILITY(U,$J,358.3,31752,2)
 ;;=^5003323
 ;;^UTILITY(U,$J,358.3,31753,0)
 ;;=F16.20^^138^1454^2
 ;;^UTILITY(U,$J,358.3,31753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31753,1,3,0)
 ;;=3^Phencyclidine Use Disorder,Moderate-Severe
 ;;^UTILITY(U,$J,358.3,31753,1,4,0)
 ;;=4^F16.20
 ;;^UTILITY(U,$J,358.3,31753,2)
 ;;=^5003336
 ;;^UTILITY(U,$J,358.3,31754,0)
 ;;=F16.21^^138^1454^3
 ;;^UTILITY(U,$J,358.3,31754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31754,1,3,0)
 ;;=3^Phencyclidine Use Disorder,Moderate-Severe,In Remission
 ;;^UTILITY(U,$J,358.3,31754,1,4,0)
 ;;=4^F16.21
 ;;^UTILITY(U,$J,358.3,31754,2)
 ;;=^5003337
 ;;^UTILITY(U,$J,358.3,31755,0)
 ;;=F11.10^^138^1455^4
 ;;^UTILITY(U,$J,358.3,31755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31755,1,3,0)
 ;;=3^Opioid Use Disorder,Mild
 ;;^UTILITY(U,$J,358.3,31755,1,4,0)
 ;;=4^F11.10
 ;;^UTILITY(U,$J,358.3,31755,2)
 ;;=^5003114
 ;;^UTILITY(U,$J,358.3,31756,0)
 ;;=F11.129^^138^1455^3
 ;;^UTILITY(U,$J,358.3,31756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31756,1,3,0)
 ;;=3^Opioid Intoxication w/o Perceptual Disturbances;Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,31756,1,4,0)
 ;;=4^F11.129
 ;;^UTILITY(U,$J,358.3,31756,2)
 ;;=^5003118
 ;;^UTILITY(U,$J,358.3,31757,0)
 ;;=F11.14^^138^1455^8
 ;;^UTILITY(U,$J,358.3,31757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31757,1,3,0)
 ;;=3^Opioid-Induced Depressive Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,31757,1,4,0)
 ;;=4^F11.14
 ;;^UTILITY(U,$J,358.3,31757,2)
 ;;=^5003119
 ;;^UTILITY(U,$J,358.3,31758,0)
 ;;=F11.182^^138^1455^10
 ;;^UTILITY(U,$J,358.3,31758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31758,1,3,0)
 ;;=3^Opioid-Induced Sleep Disorder w/ Mild Use Disorder
